Naoshi Kubo

Osaka City General Hospital

Papers

4

Total Citations

22

H-Index

4

About

Naoshi Kubo is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for gastric cancer treatment, particularly through robotic and laparoscopic surgery. His major contributions center on optimizing surgical outcomes by reducing postoperative complications, such as intra-abdominal infections and anastomotic leakage. Kubo’s work demonstrates that robotic gastrectomy can lead to less severe infectious complications compared to conventional laparoscopic approaches, especially in patients with visceral obesity—a finding supported by propensity score-matched analyses. His studies, including those comparing ultrasonic shears versus Maryland bipolar forceps and evaluating jejunal mesentery preservation, have each garnered 4–9 citations, reflecting growing clinical interest. Notably, his 2022 paper on robotic surgery’s advantage in infection control has been cited 9 times, highlighting its impact on surgical practice. Kubo’s research not only advances technical precision in gastrectomy but also provides evidence-based strategies to improve patient recovery, making him a key figure in the evolution of robotic gastric cancer surgery.

Research Focus

Key Achievements

4
H-Index
4
Papers
22
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Less Severe Intra-Abdominal Infections in Robotic Surgery for Gastric Cancer Compared with Conventional Laparoscopic Surgery: A Propensity Score-matched Analysis
9 citations · 2022
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Osaka City General Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago